Theralase Technologies Inc.
TLT.V
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -0.94% | 13.11% | -11.07% | -5.24% | -5.23% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -0.94% | 13.11% | -11.07% | -5.24% | -5.23% |
| Cost of Revenue | -8.59% | -2.19% | -14.95% | -7.20% | -2.61% |
| Gross Profit | 6.27% | 29.10% | -7.34% | -3.46% | -7.55% |
| SG&A Expenses | 2.54% | 1.57% | -4.32% | -5.34% | 7.10% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.85% | -2.12% | -3.95% | -7.41% | -3.67% |
| Operating Income | 2.06% | 5.28% | 2.30% | 7.93% | 3.32% |
| Income Before Tax | 2.51% | 6.06% | 2.68% | 8.15% | 3.80% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 2.51% | 6.06% | 2.68% | 8.15% | 3.80% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2.51% | 6.06% | 2.68% | 8.15% | 3.80% |
| EBIT | 2.06% | 5.28% | 2.30% | 7.93% | 3.32% |
| EBITDA | 1.71% | 5.04% | 1.94% | 7.88% | 3.01% |
| EPS Basic | 10.14% | 13.89% | 10.81% | 14.84% | 9.80% |
| Normalized Basic EPS | 10.47% | 14.44% | 11.83% | 15.46% | 10.42% |
| EPS Diluted | 10.14% | 13.89% | 10.81% | 14.84% | 9.80% |
| Normalized Diluted EPS | 10.47% | 14.44% | 11.83% | 15.46% | 10.42% |
| Average Basic Shares Outstanding | 8.78% | 9.03% | 9.05% | 8.57% | 6.64% |
| Average Diluted Shares Outstanding | 8.78% | 9.03% | 9.05% | 8.57% | 6.64% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |